Zippertentan Intermediate
have 0 Relevant products
Zipotentitan Is A Specific Antagonist Of Oral Active Endothelin A (Eta) Receptor, Ic50 Is 21 Nm. Zipotentitan Is An Anticancer Candidate Developed By Astrazeneca. Zipotentitan Has Been Approved By The Fda For Rapid Follow-Up Of Prostate Cancer. Zipotentit
